Business Description
Forte Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US34962G1094
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.65 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18.9 | |||||
3-Year EPS without NRI Growth Rate | 20.1 | |||||
3-Year FCF Growth Rate | 28.6 | |||||
3-Year Book Growth Rate | -40.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 8.76 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.77 | |||||
9-Day RSI | 31.46 | |||||
14-Day RSI | 31.92 | |||||
6-1 Month Momentum % | -55.41 | |||||
12-1 Month Momentum % | -49.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.82 | |||||
Quick Ratio | 2.82 | |||||
Cash Ratio | 2.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -122.25 | |||||
ROA % | -101.51 | |||||
ROIC % | -2656.22 | |||||
3-Year ROIIC % | 4718.6 | |||||
ROC (Joel Greenblatt) % | -42390.66 | |||||
ROCE % | -127.24 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.43 | |||||
Price-to-Tangible-Book | 0.43 | |||||
EV-to-EBIT | 0.46 | |||||
EV-to-EBITDA | 0.46 | |||||
EV-to-FCF | 0.56 | |||||
Price-to-Net-Current-Asset-Value | 0.44 | |||||
Price-to-Net-Cash | 0.48 | |||||
Earnings Yield (Greenblatt) % | 217.39 | |||||
FCF Yield % | -417.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Forte Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -16.959 | ||
Beta | 0.55 | ||
Volatility % | 91.29 | ||
14-Day RSI | 31.92 | ||
14-Day ATR (€) | 0.056577 | ||
20-Day SMA (€) | 6.8 | ||
12-1 Month Momentum % | -49.16 | ||
52-Week Range (€) | 6.05 - 18.75 | ||
Shares Outstanding (Mil) | 1.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Forte Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Forte Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Forte Biosciences Inc Frequently Asked Questions
What is Forte Biosciences Inc(FRA:37T)'s stock price today?
When is next earnings date of Forte Biosciences Inc(FRA:37T)?
Does Forte Biosciences Inc(FRA:37T) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |